A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

Name: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
Published: 2026
License: Public Domain

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

in-vivo multiple-myeloma

multiple myeloma (mm), in vivo, multiple myeloma, bcma, cd19, car-t, interventional, early_phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

Related documents